GlaxoSmithKline Pharmaceuticals informs about ODR portal

09 Oct 2023 Evaluate

GlaxoSmithKline Pharmaceuticals has informed that in accordance with SEBI circular dated 31st July 2023, read with circular dated 4th August 2023, regarding establishment of a common Online Dispute Resolution Portal (ODR Portal) which harnesses online conciliation and online arbitration for resolution of disputes arising in the Indian Securities Market, the Company has completed the registration on the ODR portal. The company has enclosed the link of the ODR portal and aforesaid circulars are updated on the website of the Company.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2476.65 11.75 (0.48%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×